On Sunday, April 20th 2025, starting 8:30am GMT, there will be maintenance work that will involve the website being unavailable during parts of the day. We apologize for any inconvenience this may cause and appreciate your understanding.
We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Talk outline
- What are the conventional risk factors for CHD
- The multifactorial nature of CAD
- Gene:environment interaction and risk of CAD
- Identifying gene:environment interaction
- The basis for gene:environment interactions
- Measurement of genetic and environmental factors
- What is gene environment interaction
- How to test for gene:environment interaction (1)
- How to test for gene:environment interaction (2)
- Prospective vs. case:control studies
- Candidate gene approach
- Examples of the candidate gene approach
- Northwick park heart study II
- APOE, smoking and CHD risk
- Role of ApoE and LPL in fat metabolism
- CHD risk by APOE genotype and smoking
- Can we replicate these results in another study?
- APOE E4 effect in smokers and non smokers
- APOE smoking and CHD risk mechanisms
- LPL: smoking interaction and CHD risk
- What is lipoprotein lipase and what does it do?
- Lipoprotein lipase function 1: hydrolysis
- Lipoprotein lipase function 2: bridging
- Common LPL variants
- Why are raised triglycerides a risk factor?
- LPL - a good candidate gene
- D9N, N291S: TG levels and risk of heart disease
- LPL:smoking interaction on HD risk
- Survival plot for LPL-D9N and smoking, NPHSII
- The mechanism for the LPL-D9N effect on risk
- The LPL-D9 and LPL-N9 bridging function test (1)
- The LPL-D9 and LPL-N9 bridging function test (2)
- Can we visualise the binding at 4 degrees?
- Mechanisms for LPL-N9:smoking interaction
- Nature and nurture
- Genome wide association scans
- Illumina and Affymetix CHIPs
- Results from the GWASs for CHD
- SNPSs that have been identified from GWAS
- Back to where we started
- Conclusion
Topics Covered
- Conventional CVHD risk factors
- Multifactorial nature of CVD
- Gene-environment interaction and how to test for it
- Candidate gene approach to CVD genetics vs. genome-wide scans
- Examples of the candidate gene approach and gene-environment interaction, APOE and smoking interaction, LPL and smoking
- Mechanisms for these effects
- Novel genes identified by genome-wide scans for CHD and lipid traits
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Talmud, P. (2008, November 24). Genetics of cardiovascular disease [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 15, 2025, from https://doi.org/10.69645/MBQC1651.Export Citation (RIS)
Publication History
- Published on November 24, 2008
Financial Disclosures
- Prof. Philippa Talmud has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.